Author:
Duc I.,Bonnet P.,Duranti V.,Cardinali S.,Rivière A.,De Giovanni A.,Shields-Botella J.,Barcelo G.,Adje N.,Carniato D.,Lafay J.,Pascal J.C.,Delansorne R.
Subject
Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference30 articles.
1. Molecular biology of steroid hormone synthesis;Miller;Endocrinol. Rev.,1988
2. Steroidogenic enzymes: structure, function, and role in regulation of steroid hormone biosynthesis;Hanukoglu;J. Steroid Biochem. Mol. Biol.,1992
3. Inhibitors of P450-dependent steroid biosynthesis: from research to medical treatment;Vanden Bossche;J. Steroid Biochem. Mol. Biol.,1992
4. Molecular modelling of steroidogenic cytochromes P450 from families CYP11, CYP17, CYP19 and CYP21 based on the CYP102 crystal structure;Lewis;J. Steroid Biochem. Mol. Biol.,1998
5. The regulation of 17,20 lyase activity;Miller;Steroids,1997
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Repurposing FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, and remdesivir as potential inhibitors against RNA dependent RNA polymerase of SARS-CoV-2: A comparative in silico perspective;Informatics in Medicine Unlocked;2023
2. Androgen synthesis inhibition increases behavioural flexibility and
mPFC
tyrosine hydroxylase in gonadectomized male rats;Journal of Neuroendocrinology;2022-05-18
3. Androgen synthesis inhibition but not gonadectomy reduces persistence during strategy set-shifting and reversal learning in male rats;2021-08-12
4. Inhibitory activity of FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, remdesivir, and hydroxychloroquine on COVID-19 main protease and human ACE2 receptor: A comparative in silico approach;Informatics in Medicine Unlocked;2021
5. Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system;Pharmacological Research;2020-09